Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Marthe M de Jonge"'
Autor:
Tjalling Bosse, Brooke E. Howitt, Vincent T.H.B.M. Smit, Flora E. van Leeuwen, Christi J. van Asperen, Matti A. Rookus, Harry Hollema, Rutika Puranik, Jeremy P. Segal, Maaike P.G. Vreeswijk, Cornelis D. de Kroon, Lauren L. Ritterhouse, Marthe M. de Jonge
Class 4/5 mutations and Tumor Mutational Burden stratified by loss of heterozygosity status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6554e3d74b2a412bff760bc43f3ef6
https://doi.org/10.1158/1078-0432.22471688.v1
https://doi.org/10.1158/1078-0432.22471688.v1
Autor:
Tjalling Bosse, Brooke E. Howitt, Vincent T.H.B.M. Smit, Flora E. van Leeuwen, Christi J. van Asperen, Matti A. Rookus, Harry Hollema, Rutika Puranik, Jeremy P. Segal, Maaike P.G. Vreeswijk, Cornelis D. de Kroon, Lauren L. Ritterhouse, Marthe M. de Jonge
Germline BRCA1/2 Mutations and Variant Allele Frequencies detected in the FFPE-isolated tumor DNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::655b5ef24d6d98e1df3215e63f754e88
https://doi.org/10.1158/1078-0432.22471679.v1
https://doi.org/10.1158/1078-0432.22471679.v1
Autor:
Tjalling Bosse, Brooke E. Howitt, Vincent T.H.B.M. Smit, Flora E. van Leeuwen, Christi J. van Asperen, Matti A. Rookus, Harry Hollema, Rutika Puranik, Jeremy P. Segal, Maaike P.G. Vreeswijk, Cornelis D. de Kroon, Lauren L. Ritterhouse, Marthe M. de Jonge
Purpose:Whether endometrial carcinoma (EC) should be considered part of the gBRCA1/2-associated hereditary breast and ovarian cancer (HBOC) syndrome is topic of debate. We sought to assess whether ECs occurring in gBRCA carriers are enriched for clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2abbf9306faf63e830bdd8b26ecb3cd7
https://doi.org/10.1158/1078-0432.c.6527963.v1
https://doi.org/10.1158/1078-0432.c.6527963.v1
Autor:
Tjalling Bosse, Maaike P.G. Vreeswijk, Alexandra Leary, Etienne Rouleau, Cor D. de Kroon, Yannick Boursin, Bastien Job, Harry Vrieling, David N. Church, Mark A. Glaire, Remi A. Nout, Vincent T.H.B.M. Smit, Natalja T. ter Haar, Matty Meijers, Philip C. Schouten, Lise M. van Wijk, Aurélie Auguste, Marthe M. de Jonge
Supplementary Material and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17d9d1e6d547375ed6a6fe0b5b87a231
https://doi.org/10.1158/1078-0432.22468142
https://doi.org/10.1158/1078-0432.22468142
Autor:
Tjalling Bosse, Maaike P.G. Vreeswijk, Alexandra Leary, Etienne Rouleau, Cor D. de Kroon, Yannick Boursin, Bastien Job, Harry Vrieling, David N. Church, Mark A. Glaire, Remi A. Nout, Vincent T.H.B.M. Smit, Natalja T. ter Haar, Matty Meijers, Philip C. Schouten, Lise M. van Wijk, Aurélie Auguste, Marthe M. de Jonge
Purpose:The elevated levels of somatic copy-number alterations (SCNAs) in a subset of high-risk endometrial cancers are suggestive of defects in pathways governing genome integrity. We sought to assess the prevalence of homologous recombination defic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff2fda19256b3d5f75f17c7ebe98757
https://doi.org/10.1158/1078-0432.c.6526850.v1
https://doi.org/10.1158/1078-0432.c.6526850.v1
Autor:
Tjalling Bosse, Maaike P.G. Vreeswijk, Alexandra Leary, Etienne Rouleau, Cor D. de Kroon, Yannick Boursin, Bastien Job, Harry Vrieling, David N. Church, Mark A. Glaire, Remi A. Nout, Vincent T.H.B.M. Smit, Natalja T. ter Haar, Matty Meijers, Philip C. Schouten, Lise M. van Wijk, Aurélie Auguste, Marthe M. de Jonge
Figure S1 shows that the Oncoscan and CGH agilent platform yield similar results.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a0c87cfd751bf45c1d1b144c1ed9b57
https://doi.org/10.1158/1078-0432.22468148
https://doi.org/10.1158/1078-0432.22468148
Autor:
Tjalling Bosse, Maaike P.G. Vreeswijk, Alexandra Leary, Etienne Rouleau, Cor D. de Kroon, Yannick Boursin, Bastien Job, Harry Vrieling, David N. Church, Mark A. Glaire, Remi A. Nout, Vincent T.H.B.M. Smit, Natalja T. ter Haar, Matty Meijers, Philip C. Schouten, Lise M. van Wijk, Aurélie Auguste, Marthe M. de Jonge
Table S1 shows the clinicopathological characteristics of the cases included in final analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::478ebbf175a1a412e395f325e3a52f47
https://doi.org/10.1158/1078-0432.22468139.v1
https://doi.org/10.1158/1078-0432.22468139.v1
Autor:
Tjalling Bosse, Brooke E. Howitt, Vincent T.H.B.M. Smit, Flora E. van Leeuwen, Christi J. van Asperen, Matti A. Rookus, Harry Hollema, Rutika Puranik, Jeremy P. Segal, Maaike P.G. Vreeswijk, Cornelis D. de Kroon, Lauren L. Ritterhouse, Marthe M. de Jonge
Supplementary Material and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0e57c2ec183c18a91be3f5ba5fd4510
https://doi.org/10.1158/1078-0432.22471685
https://doi.org/10.1158/1078-0432.22471685
Autor:
Katja N. Gaarenstroom, Claire J H Kramer, Lise M van Wijk, Tjalling Bosse, Harry Vrieling, Cor D. de Kroon, Judith R. Kroep, S. Vermeulen, Marthe M de Jonge, Natalja T. ter Haar, Maaike P.G. Vreeswijk
Publikováno v:
Cancers, 13(12), 2994. MDPI} {AG
Cancers
Cancers, Vol 13, Iss 2994, p 2994 (2021)
Cancers
Cancers, Vol 13, Iss 2994, p 2994 (2021)
Simple Summary Rapid and reliable identification of patients with homologous recombination deficient (HRD) tumors is important for treatment choice as these tumors tend to respond well to platinum-based chemotherapy and PARP inhibitors (PARPi). In th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91077617985b09704101321a36dda3c2
https://hdl.handle.net/1887/3250622
https://hdl.handle.net/1887/3250622
Publikováno v:
J Natl Cancer Inst